Randomised, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Study of QGC001, a Centrally Acting Aminopeptidase A Inhibitor Prodrug
2013 ◽
Vol 53
(4)
◽
pp. 385-395
◽
Keyword(s):
Phase I
◽
2017 ◽
Vol 35
◽
pp. e36
◽
2013 ◽
Vol 94
(5)
◽
pp. 593-600
◽
2018 ◽
Vol 56
(11)
◽
pp. 507-517
◽